Europe Neurotherapeutics Market by Treatment - (Neurologic Drugs, Neurologic Devices), by disorders – (Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders), by distribution channels (Hospitals, Neurotherapeutic center, Clinical research organisations, Clinics) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
- Advertising -
Europe has the second highest share in the market due to increasing awareness among people over various neurological conditions.
View report at: www.marketdataforecast.com/market-…tics-market-1272/
Neurological conditions results in damage to the brain, spinal nerves or column that is caused by injury or illness. The precise causes for many of the neurological conditions are not yet known.
These disorder can affect men and women, young and old and people from all cultures.
- Advertising -
Some of these conditions like cerebral palsy, are present from birth, and Alzheimer’s disease, Parkinson’s disease affect mainly older people. These disorders involve progressive deterioration in mental and physical capabilities which disrupts the patient and patient’s family.
So, Neurotherapeutics are used for the treatment of traumas causing diseases.
Europe Neurotherapeutics Market is mainly driven by increasing aging population, growing R&D expenditure, a better understanding of the nature of neurologic diseases. Aged population are more susceptible to brain disorders.
Therefore, the rise in aging population and life expectancy of the people will increase the market. The restraints that will hamper the growth of the market are restrictions by regulatory bodies on various technologies and drugs.
Based on Treatment, the market is segmented into Neurologic drugs and Neurologic devices. Neurologic drugs are further classified into oral administration, injections and others.
Whereas neurologic devices are further categorized into Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), transcranial magnetic stimulation, Deep Brain Stimulator, and others. Based on disorders, the market is segmented into Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders.
Based on distribution channels the market is segmented into Hospitals, Neurotherapeutic center, Clinical research organizations, Clinics. Based on Geography, the Europe Neurotherapeutics market is analyzed under various regions namely U.K, Germany, France, Italy and Spain.
Some of the major players in Europe Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.
- Neurologic Drugs
-Electroconvulsive Therapy (ECT)
-Vagus Nerve Stimulation (VNS)
-Transcranial magnetic stimulation
-Deep Brain Stimulator
- Y-o-Y Growth Analysis, By Product
- Market Attractiveness Analysis, By Product
- Market Share Analysis, By Product
- Central Nervous system disorder
- Peripheral Nervous system disorder
- Autonomous Nervous system disorder
- Y-o-Y Growth Analysis, By Type
- Market Attractiveness Analysis, By Type
- Market Share Analysis, By Type
- Neurotherapeutic center
- Clinical Research organisations
- Y-o-Y Growth Analysis, By Application
- Market Attractiveness Analysis, By Application
- Market Share Analysis, By Application
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: